1. Home
  2. GKOS vs IFS Comparison

GKOS vs IFS Comparison

Compare GKOS & IFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$116.17

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo Intercorp Financial Services Inc.

IFS

Intercorp Financial Services Inc.

HOLD

Current Price

$49.67

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
IFS
Founded
1998
1897
Country
US
US
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.3B
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
GKOS
IFS
Price
$116.17
$49.67
Analyst Decision
Strong Buy
Buy
Analyst Count
14
1
Target Price
$133.07
$48.00
AVG Volume (30 Days)
770.3K
252.7K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
1.92%
EPS Growth
0.36
N/A
EPS
N/A
N/A
Revenue
$383,481,000.00
N/A
Revenue This Year
$23.29
N/A
Revenue Next Year
$27.74
$3.27
P/E Ratio
N/A
$9.61
Revenue Growth
21.85
N/A
52 Week Low
$73.16
$29.09
52 Week High
$142.50
$52.58

Technical Indicators

Market Signals
Indicator
GKOS
IFS
Relative Strength Index (RSI) 52.32 58.26
Support Level $103.55 $46.78
Resistance Level $121.70 $52.22
Average True Range (ATR) 5.70 1.79
MACD -0.23 -0.39
Stochastic Oscillator 63.83 51.85

Price Performance

Historical Comparison
GKOS
IFS

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About IFS Intercorp Financial Services Inc.

Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services and payments for retail customers and commercial clients in Peru. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services. Its geographical segments include Peru and Panama.

Share on Social Networks: